5 Spam-Free Article(s) Found
https://seekingalpha.com/news/4463660-inmune-bio-fails-to-meet-main-goal-in-alzheimers-treatment-study?source=feed_sector_healthcare
Jun 30, 2025 -
0
sa:7003357070546312088
0
https://www.rttnews.com/story.aspx?Id=3549728
Jun 30, 2025 - INmune Bio Inc. (INMB) Monday said that its Phase 2 MINDFuL study of XPro in patients with early Alzheimers Disease (AD) with biomarkers of inflammation did not meet its primary goal. The company's shares were more than 50% down in pre-market.
0
rttnews:3467593296171353842
0
https://seekingalpha.com/news/4463366-inmune-bio-stock-falls-stock-offering?source=feed_sector_healthcare
Jun 27, 2025 -
0
sa:5763928725383854816
0
https://seekingalpha.com/news/4462943-vor-bio-stock-surges-private-placement?source=feed_sector_healthcare
Jun 26, 2025 -
0
sa:4349082518757969725
0
https://seekingalpha.com/news/4462458-vor-bio-announces-175m-private-placement?source=feed_sector_healthcare
Jun 25, 2025 -
0
sa:6073690268428017937
0